rivaroxaban intas 15 mg filmtabletten
rivaroxaban intas 20 mg filmtabletten
rivaroxaban intas 2,5 mg filmtabletten
rivaroxaban intas 10 mg filmtabletten
lacosamid intas 100 mg brausetabletten
lacosamid intas 150 mg brausetabletten
lacosamid intas 200 mg brausetabletten
lacosamid intas 50 mg brausetabletten
pirfenidon intas 267 mg filmtabletten
exemestane intas exemestane 25mg tablet blister pack
accord healthcare pty ltd - exemestane, quantity: 25 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; sodium starch glycollate type a; hypromellose; mannitol; microcrystalline cellulose; magnesium stearate; crospovidone; polysorbate 80; titanium dioxide; macrogol 400 - exemestane is indicated for the sequential adjuvant treatment of oestrogen receptor-positive early breast cancer in post-menopausal women who have received prior adjuvant tamoxifen therapy. . exemestane is indicated for the treatment of oestrogen receptor-positive advanced breast cancer in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy.